All Stories

  1. Appearance and Disappearance of Intracranial Aneurysm Wall Enhancement during Follow-Up: A Multicenter Cohort Study
  2. Proteomic Discovery Study of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
  3. Factors Affecting Outcomes Following Mini-Craniotomy Evacuation of Primary Chronic Subdural Hematoma: A Single-Center Retrospective Study
  4. Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study
  5. Factors affecting outcomes following burr hole drainage of chronic subdural hematoma: a single-center retrospective study
  6. Cranial Nerve Palsies and Peri-Mesencephalic Subarachnoid Haemorrhage: A Case Report and Review of the Literature
  7. Computational fluid dynamics and shape analysis enhance aneurysm rupture risk stratification
  8. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  9. Microsurgical Treatment of Intracranial Dural Arteriovenous Fistulas: A Collaborative Investigation From the Multicenter Consortium for Dural Arteriovenous Fistula Outcomes Research
  10. Quantification of blood and CSF volume to predict outcome after aneurysmal subarachnoid hemorrhage
  11. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  12. A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage — The SAS Study
  13. Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematoma
  14. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial
  15. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI)
  16. Basilar artery perforator aneurysms: a comparison with non-perforator saccular aneurysms
  17. A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
  18. Dural arteriovenous fistulas are not observed to convert to a higher grade after partial embolization
  19. Red Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies
  20. A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall Imaging
  21. An assistive listening device improves hearing following aneurysmal subarachnoid haemorrhage
  22. Gadolinium-enhanced intracranial aneurysm wall imaging and risk of aneurysm growth and rupture: a multicentre longitudinal cohort study
  23. Dural Arteriovenous Fistulas With Cognitive Impairment: Angiographic Characteristics and Treatment Outcomes
  24. The Haptoglobin Response after Aneurysmal Subarachnoid Haemorrhage
  25. Risk of subarachnoid haemorrhage reduces with blood pressure values below hypertensive thresholds
  26. Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
  27. Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma
  28. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma – protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial
  29. Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation
  30. Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma
  31. Aneurysm management in patients over 80 years old with good grade subarachnoid haemorrhage
  32. The VEBAS score: a practical scoring system for intracranial dural arteriovenous fistula obliteration
  33. The association between acetylsalicylic acid and subarachnoid haemorrhage: the Framingham Heart Study
  34. Risk of Aneurysm Rupture (ROAR) study: protocol for a long-term, longitudinal, UK multicentre study of unruptured intracranial aneurysms
  35. Sphingosine-1-phosphate Signalling in Aneurysmal Subarachnoid Haemorrhage: Basic Science to Clinical Translation
  36. Time to evacuation of acute subdural and extradural haematoma: prospective study before and after implementation of a major trauma centre
  37. Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration
  38. Functional effects of haemoglobin can be rescued by haptoglobin in anin vitromodel of subarachnoid haemorrhage
  39. Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices
  40. Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage
  41. A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis
  42. Radiological follow-up of endovascularly treated intracranial aneurysms: a survey of current practice in the UK and Ireland
  43. Genetic variation inNFE2L2is associated with outcome following aneurysmal subarachnoid haemorrhage
  44. Comparison of Suspected and Confirmed Internal External Ventricular Drain-Related Infections: A Prospective Multicenter United Kingdom Observational Study
  45. Long‐term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employment
  46. Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas
  47. Aspirin and Subarachnoid Haemorrhage in the UK Biobank
  48. Evaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months
  49. Risk of Early Versus Later Rebleeding From Dural Arteriovenous Fistulas With Cortical Venous Drainage
  50. Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage
  51. Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation
  52. Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR): rationale, design, and initial characterization of patient cohort
  53. Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes
  54. Intervention for unruptured high-grade intracranial dural arteriovenous fistulas: a multicenter study
  55. Recurrence after cure in cranial dural arteriovenous fistulas: a collaborative effort by the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR)
  56. Auditory outcome following aneurysmal subarachnoid haemorrhage
  57. Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol
  58. Pulsatile tympanic membrane displacement is associated with cognitive score in healthy subjects
  59. Long-Term Cognitive Outcome following Aneurysmal Subarachnoid Haemorrhage
  60. A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom
  61. CRP (C-Reactive Protein) in Outcome Prediction After Subarachnoid Hemorrhage and the Role of Machine Learning
  62. Outcome Following Hemorrhage From Cranial Dural Arteriovenous Fistulae
  63. Estimating confidence intervals for cerebral autoregulation: a parametric bootstrap approach
  64. Utility of image-guided external ventriculostomy: analysis of contemporary practice in the United Kingdom and Ireland
  65. Psychological distress after subarachnoid haemorrhage: A systematic review and meta-analysis
  66. Age-related changes in Tau and Autophagy in human brain in the absence of neurodegeneration
  67. First Report of a Multicenter Prospective Registry of Cranioplasty in the United Kingdom and Ireland
  68. Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI Study
  69. A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population
  70. Onyx embolization for dural arteriovenous fistulas: a multi-institutional study
  71. Observation Versus Intervention for Low-Grade Intracranial Dural Arteriovenous Fistulas
  72. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage
  73. ANGPTL6 Genetic Variants Are an Underlying Cause of Familial Intracranial Aneurysms
  74. A vascular subtraction method for improving the variability of evoked tympanic membrane displacement measurements
  75. Neurofilament light predicts neurological outcome after subarachnoid haemorrhage
  76. Sonic Hedgehog Signaling Promotes Peri-Lesion Cell Proliferation and Functional Improvement after Cortical Contusion Injury
  77. Trial of Dexamethasone for Chronic Subdural Hematoma
  78. Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  79. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  80. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
  81. Intracranial Masson Lesion Following Stereotactic Radiosurgery for Treatment of Intracranial Arteriovenous Malformations
  82. Assessment of the Subarachnoid Hemorrhage International Trialists (SAHIT) Models for Dichotomized Long-Term Functional Outcome Prediction After Aneurysmal Subarachnoid Hemorrhage in a United Kingdom Multicenter Cohort Study
  83. Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons
  84. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
  85. Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
  86. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study
  87. Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)
  88. Vasomotion Drives Periarterial Drainage of Aβ from the Brain
  89. Age dependent changes in synaptic NMDA receptor composition in adult human cortical neurons
  90. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study
  91. Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage
  92. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage
  93. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin
  94. Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA)
  95. Time to surgery following chronic subdural hematoma: post hoc analysis of a prospective cohort study
  96. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation
  97. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage
  98. A primate-specific short GluN2A-NMDA receptor isoform is expressed in the human brain
  99. Vessel Wall Imaging After Subarachnoid Hemorrhage in Patients with Multiple Intracranial Aneurysms: A Cautionary Case
  100. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury
  101. Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential
  102. Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
  103. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage
  104. Image guidance and improved accuracy of external ventricular drain tip position particularly in patients with small ventricles
  105. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004–2013)
  106. Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  107. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
  108. Safety, accuracy, and cost effectiveness of bedside bolt external ventricular drains (EVDs) in comparison to tunnelled EVDs inserted in theatres
  109. Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
  110. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?
  111. Hearing impairment after subarachnoid hemorrhage
  112. SVM Optimization for Brain Tumor Identification Using Infrared Spectroscopic Samples
  113. Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  114. BRIDGING THE GAP – BENEFITS OF NEUROSURGICAL TISSUE FOR PRE-CLINICAL RESEARCH
  115. Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland
  116. Does Drain Position and Duration Influence Outcomes in Patients Undergoing Burr-Hole Evacuation of Chronic Subdural Hematoma? Lessons from a UK Multicenter Prospective Cohort Study
  117. Quantifying the contribution of intracranial pressure and arterial blood pressure to spontaneous tympanic membrane displacement
  118. Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”
  119. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications
  120. Anatomy of spaces around blood vessels in cerebral amyloid angiopathy
  121. Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma
  122. The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome
  123. Outcomes of Microsurgical Clipping of Recurrent Aneurysms After Endovascular Coiling
  124. Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations
  125. Refining non-invasive techniques to measure intracranial pressure: comparing evoked and spontaneous tympanic membrane displacements
  126. A subarachnoid haemorrhage-specific outcome tool
  127. An Intraoperative Visualization System Using Hyperspectral Imaging to Aid in Brain Tumor Delineation
  128. An Evaluation of Commonly Used External Ventricular Drain Securement Methods in a Porcine Model: Recommendations to Improve Practice
  129. Reference intervals for the evoked tympanic membrane displacement measurement: a non-invasive measure of intracranial pressure
  130. Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis
  131. Does the Variability of Evoked Tympanic Membrane Displacement Data (V m) Increase as the Magnitude of the Pulse Amplitude Increases?
  132. Mentoring models in neurosurgical training: Review of literature
  133. Degree and Duration of Functional Improvement on Long-Term Follow-Up of Spinal Dural Arteriovenous Fistulae Occluded by Endovascular and Surgical Treatment
  134. The Resolution of Oculomotor Nerve Palsy Caused by Unruptured Posterior Communicating Artery Aneurysms: A Cohort Study and Narrative Review
  135. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland
  136. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom
  137. CSF inflammatory response after intraventricular hemorrhage
  138. What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
  139. Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case–Control Study
  140. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  141. Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature
  142. P04.20 Hyperspectral imaging for brain tumour identification and boundaries delineation in real-time during neurosurgical operations
  143. Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis
  144. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
  145. The effect of direction of force to the craniofacial skeleton on the severity of brain injury in patients with a fronto-basal fracture
  146. The use of human neurons for novel drug discovery in dementia research
  147. Heme–Hemopexin Scavenging Is Active in the Brain and Associates With Outcome After Subarachnoid Hemorrhage
  148. Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage
  149. Pharmacologic Management of Subarachnoid Hemorrhage
  150. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
  151. Nitric Oxide Synthase Inhibition with the Antipterin VAS203 Improves Outcome in Moderate and Severe Traumatic Brain Injury: A Placebo-Controlled Randomized Phase IIa Trial (NOSTRA)
  152. External ventricular drainage: Is it time to look at national practice?
  153. Haemoglobin Scavenging After Subarachnoid Haemorrhage
  154. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial
  155. Alternative cost-effective method to record 3D intra-operative images: A technical note
  156. Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR)
  157. Recovery of oculomotor nerve palsy secondary to posterior communicating artery aneurysms
  158. A 73 Year-Old Man with a Mass at the Foramen Magnum
  159. Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland
  160. A Randomized Controlled Trial of Prophylactic Intra-aortic Balloon Counterpulsation in High-Risk Aneurysmal Subarachnoid Hemorrhage
  161. Impairment of Cerebral Autoregulation Predicts Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
  162. The SILVER (Silver Impregnated Line Versus EVD Randomized Trial)
  163. A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years
  164. Pathological laughter and crying in patients with pontine lesions
  165. Response to: A web-based referral system for neurosurgery; a solution to our problems?
  166. The Natural History of Cranial Dural Arteriovenous Fistulae With Cortical Venous Reflux—The Significance of Venous Ectasia
  167. Neurenteric cyst of the anterior cranial fossa: case report and literature review
  168. Causes of neurological deficits following clipping of 200 consecutive ruptured aneurysms in patients with good-grade aneurysmal subarachnoid haemorrhage
  169. Chordoma of the anterior skull base presenting as a swelling of the medial canthus of the eye
  170. Placement of silicone sheeting at decompressive craniectomy to prevent adhesions at cranioplasty
  171. Visual recovery following optic nerve decompression for chronic compressive neuropathy
  172. A prospective study of the time to evacuate acute subdural and extradural haematomas
  173. An alternative method of wound pain control following hepatic resection: a preliminary study
  174. Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region
  175. Opioid receptor regulation of muscarinic acetylcholine receptor-mediated synaptic responses in the hippocampus
  176. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by GABABreceptors in the rat hippocampus
  177. Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region
  178. Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus